Navigation Links
Abbott's TRILIPIX(R) (Fenofibric Acid) in Combination With Rosuvastatin Calcium Helps Patients With Mixed Dyslipidemia and Type 2 Diabetes Meet American Diabetes Association Lipid Targets
Date:6/8/2009

Post-hoc analysis of two large clinical trials showed combination therapy helped more patients reach combined targets for HDL, triglycerides and LDL than the pre-determined therapy alone

NEW ORLEANS, June 8 /PRNewswire-FirstCall/ -- Abbott's (NYSE: ABT) TRILIPIX (R) (fenofibric acid) delayed-release capsules in combination with rosuvastatin calcium achieved individual and combined lipid targets in patients with mixed dyslipidemia and type 2 diabetes. In these patients, the combination of TRILIPIX and rosuvastatin helped up to three times more patients simultaneously reach all three key lipid targets - HDL, triglycerides and LDL - than the pre-determined monotherapy. Results from this post-hoc analysis were presented today at the American Diabetes Association's 2009 Scientific Sessions.

TRILIPIX is a prescription medicine used along with diet to lower triglycerides and LDL (bad) cholesterol, and increase HDL (good) cholesterol. TRILIPIX is also used along with diet to lower triglycerides and increase HDL cholesterol in people who are at high risk of heart disease and are taking a statin medicine to control their LDL cholesterol. TRILIPIX has not been shown to prevent heart attacks or stroke more than a statin alone.

Dyslipidemia affects millions of Americans living with diabetes. These patients often have mixed dyslipidemia, a combination of two or more lipid problems including low HDL, high triglycerides and high LDL.

"Because diabetes is a risk factor for heart disease, it is particularly important that patients with diabetes and mixed dyslipidemia manage all three key lipid parameters," said Robert Rosenson, M.D., State University of New York, Brooklyn, New York. "The results of this analysis are promising for combination therapy with TRILIPIX and rosuvastatin."

<
'/>"/>
SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of TRILIPIX(R) (fenofibric acid)
2. (Multimedia Version): Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management
3. Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management
4. QLT announces positive results from the evaluation of Visudyne(R) combination therapy
5. 2-drug combination appears safe and active in metastatic kidney cancer
6. New treatment combination proves safe for head and neck cancer patients
7. Study shows drug combination improves outcome for advanced non-small cell lung cancer
8. Chemotherapy combination outcomes differ for aged, younger colon cancer patients
9. Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer
10. Transplant Surgery and Identity: A Discussion Among Pioneers with Unusual Combinations of Interests, Skills and Talents
11. Mayo Clinic Researchers Say Triple Drug Combination is Promising Option to Treat Metastatic HER2+ Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... San Francisco, CA (PRWEB) July 31, 2014 ... North Carolina-based SAS Institute Inc. (SAS) to ... Health Care Center (HCC). , SAS is one of ... approximately 13,600 people worldwide. More than 40,000 patients are ... Carolina. , In addition to delivering primary care, providers ...
(Date:7/31/2014)... OK (PRWEB) July 31, 2014 Shiitakes ... As in the recipe for Quick-Fix Spaghetti Sauce below, ... second-most consumed mushroom worldwide, valued for their deep flavor ... mushrooms. They absorb flavors of the foods they're cooked ... texture and offer high-protein, low-fat nutrition. Shiitakes are rich ...
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 ... have published the largest study to ... through either teledermoscopy or traditional letter referral systems ... smartphone referrals via patent pending iDoc24® technology provided ... with skin cancer while potentially eliminating unnecessary visits. ...
(Date:7/31/2014)... A class of medications previously linked to cognitive ... affect their physical functioning according to investigators from ... for Aging Research, the University of East Anglia ... a systemic review of more than a decade ... anticholinergic properties, they report that these drugs have ...
(Date:7/31/2014)... of vacuum pressure is a promising approach to limiting ... experimental study in the August issue of ... of Neurological Surgeons . The journal is published by ... Wolters Kluwer Health . , "Mechanical tissue ... of the brainshows promise as a safe and effective ...
Breaking Medicine News(10 mins):Health News:SAS Selects i2i Systems for Health Care Center Patient Referral Database 2Health News:SAS Selects i2i Systems for Health Care Center Patient Referral Database 3Health News:Quick Fixin’ Summertime Meals with Shiitake Mushrooms -- Bring ‘em Home and Grow Your Own 2Health News:Quick Fixin’ Summertime Meals with Shiitake Mushrooms -- Bring ‘em Home and Grow Your Own 3Health News:Smartphone iDoc 24 Technology Speeds Time to Diagnosis and Treatment for Skin Cancer Patients 2Health News:Smartphone iDoc 24 Technology Speeds Time to Diagnosis and Treatment for Skin Cancer Patients 3Health News:Smartphone iDoc 24 Technology Speeds Time to Diagnosis and Treatment for Skin Cancer Patients 4Health News:Common drugs adversely impair older adults' physical as well as cognitive functioning 2Health News:Vacuum treatment may limit damage after traumatic brain injury 2
... Seniors: "The Best Things in Life are FREE!",including an eye exam ... ... San Francisco, CA -- This February, EyeCare America is reminding seniors ... you can,t put a price tag on love, friendship or the ...
... America,s Health (TFAH) strongly supports President Obama,s call for ... The latest outbreak of Salmonella tied to ... and Salmonella outbreaks in 2008 highlight ... practices. TFAH released a comprehensive report, Fixing Food ...
... Health System researchers have published new data to help answer ... treatment should I have?" , Cancer is the primary ... features of a lesion usually provide clues about whether it ... clear-cut, and doctors are faced with the question of how ...
... health conscious and the sports enthusiast SANTA BARBARA, ... Bulletin Board: WNYN), the premier provider of robust ... of the business-to-consumer (B2C) site VitaminRX.com ... platform. The VitaminRX.com website features health supplements, sports ...
... LAKE FOREST, Ill., Feb. 2 The ... published study results demonstrating,Hospira, Inc.,s (NYSE: ... for intravenous sedation provides comparable effectiveness to,commonly ... of mechanically ventilated patients in the,intensive care ...
... standard of care, researcher says , , MONDAY, Feb. 2 (HealthDay ... stay on ventilators and results in less delirium than other ... a new study finds. , For patients in ICUs, delirium ... extended period; it can affect as many as 85 percent ...
Cached Medicine News:Health News:During February's Valentine's Promotion EyeCare America Offers No-Cost Medical Eye Care to Qualified Seniors 2Health News:During February's Valentine's Promotion EyeCare America Offers No-Cost Medical Eye Care to Qualified Seniors 3Health News:Trust for America's Health Applauds President Obama's Call for a Complete Review of the U.S. Food Safety System 2Health News:Trust for America's Health Applauds President Obama's Call for a Complete Review of the U.S. Food Safety System 3Health News:Rare skin tumor responds better to treatment than melanoma 2Health News:Rare skin tumor responds better to treatment than melanoma 3Health News:Warp 9 Launches VitaminRX.com 2Health News:Hospira's Precedex(R) Phase IV Study Published in the Journal of the American Medical Association 2Health News:Hospira's Precedex(R) Phase IV Study Published in the Journal of the American Medical Association 3Health News:Hospira's Precedex(R) Phase IV Study Published in the Journal of the American Medical Association 4Health News:Newer Sedative May Reduce Delirium in ICU Patients 2Health News:Newer Sedative May Reduce Delirium in ICU Patients 3
(Date:7/31/2014)... SPRINGS, Colo. , July 31, 2014 /PRNewswire/ ... specializing in cannabis formulation-based drug development and related ... commenced production of multiple strains of cannabis and ... research to select the best strains for development ... bring the cannabis formulations to market for critical ...
(Date:7/31/2014)... the list of stocks featured in the Analyst Blog. Every ... and events impacting stocks and the financial markets. Stocks recently ... Free Report ), Gilead (Nasdaq: GILD - Free Report ... AbbVie (NYSE: ABBV - Free Report ) and Celgene ... Zacks is promoting its ,Buy, stock recommendations. Get #1Stock ...
(Date:7/31/2014)... , July 31, 2014 For the first ... watch the implantation of the SynCardia temporary Total Artificial ... matching video posted on the Journal of Visualized Experiments ... read the paper on the SynCardia Total Artificial Heart ... video accompanies "Implantation of the SynCardia Total Artificial Heart," ...
Breaking Medicine Technology:Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3
... N.J., Jan. 14, 2011 McNeil Consumer Healthcare Division of ... ) company, in July 2010 submitted to the FDA a ... to restore its operations to the level of quality and ... As part of this commitment, McNeil undertook a thorough investigation ...
... research data suggests that [18F] Flutemetamol could add value ... accurate identification of beta amyloid plaques, considered to be ... Flutemetamol, a GE Healthcare Positron Emission Tomography (PET) imaging ... to identify the uptake of beta amyloid via imaging ...
Cached Medicine Technology:Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan 2GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease 2GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease 3
... The Shandon Cytospin has been ... 35 years. More than 15,000 ... reliable instrument. It provides economical ... matrix, especially hypocellular fluids such ...
... Finger Traps for optimum patient comfort. The Nylon ... with a firm grip. ISI Nylon Finger Traps ... when used with the ISI Digi Grip or ... Traps are available in non-sterile packs and come ...
Spacelabs offers an approach that allows your telemetry and step-down units to configure systems to meet their telemetry requirements. Our modular telemetry system data are integrated into the depart...
The Tele-Pro WEP-4200 Telemetry System is an 8-Patient Stand Alone System. Offering capabilities such as arrhythmia analysis, trends and full disclosure, the Tele-Pro is a system to help hospitals to...
Medicine Products: